PuSH - Publication Server of Helmholtz Zentrum München

Zhou, Q.* ; Mareljic, N.* ; Michaelsen, M.* ; Parhizkar, S.* ; Heindl, S.* ; Nuscher, B.* ; Farny, D.* ; Czuppa, M.* ; Schludi, C.* ; Graf, A.* ; Krebs, S.* ; Blum, H.* ; Feederle, R. ; Roth, S.* ; Haass, C.* ; Arzberger, T.* ; Liesz, A.* ; Edbauer, D.*

Active poly-GA vaccination prevents microglia activation and motor deficits in a C9orf72 mouse model.

EMBO Mol. Med. 12:e10919 (2020)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The C9orf72 repeat expansion is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD). Non-canonical translation of the expanded repeat results in abundant poly-GA inclusion pathology throughout the CNS. (GA)(149)-CFP expression in mice triggers motor deficits and neuroinflammation. Since poly-GA is transmitted between cells, we investigated the therapeutic potential of anti-GA antibodies by vaccinating (GA)(149)-CFP mice. To overcome poor immunogenicity, we compared the antibody response of multivalent ovalbumin-(GA)(10) conjugates and pre-aggregated carrier-free (GA)(15). Only ovalbumin-(GA)(10) immunization induced a strong anti-GA response. The resulting antisera detected poly-GA aggregates in cell culture and patient tissue. Ovalbumin-(GA)(10) immunization largely rescued the motor function in (GA)(149)-CFP transgenic mice and reduced poly-GA inclusions. Transcriptome analysis showed less neuroinflammation in ovalbumin-(GA)(10)-immunized poly-GA mice, which was corroborated by semiquantitative and morphological analysis of microglia/macrophages. Moreover, cytoplasmic TDP-43 mislocalization and levels of the neurofilament light chain in the CSF were reduced, suggesting neuroaxonal damage is reduced. Our data suggest that immunotherapy may be a viable primary prevention strategy for ALS/FTD in C9orf72 mutation carriers.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
8.821
2.057
15
21
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Amyotrophic Lateral Sclerosis ; C9orf72 ; Frontotemporal Dementia ; Immunotherapy ; Neurodegeneration; Dipeptide-repeat Proteins; To-cell Transmission; Alpha-synuclein; Hexanucleotide Repeat; Cerebrospinal-fluid; Alzheimers-disease; Kappa-b; Tau; Pathology; Immunotherapy
Language english
Publication Year 2020
Prepublished in Year 2019
HGF-reported in Year 2019
ISSN (print) / ISBN 1757-4676
e-ISSN 1757-4684
Quellenangaben Volume: 12, Issue: 2, Pages: , Article Number: e10919 Supplement: ,
Publisher Wiley
Publishing Place Chichester
Reviewing status Peer reviewed
Institute(s) CF Monoclonal Antibodies (CF-MAB)
POF-Topic(s) 30201 - Metabolic Health
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502210-001
Scopus ID 85077029485
PubMed ID 31858749
Erfassungsdatum 2020-01-10